Welcome to Record Town

Welcome to LazyListen. This is The Daily Rip for today. Markets kicked off the week with some strong after-hours moves, led by Palantir and Snap, both beating expectations and sending their shares sharply higher.

Let’s break down the key takeaways and what’s ahead. Starting with the macro backdrop, investors are digesting a mix of solid earnings and upcoming economic data. Tomorrow, keep an eye on the trade balance report early in the morning, followed by the Job Openings and Labor Turnover Survey, or JOLTS, and factory orders later in the session.

These reports will give fresh clues on the health of the economy and labor market dynamics, setting the tone for the rest of the week. Now to the standout earnings. I.

software firm, crushed expectations with a nearly ninety three percent revenue jump to just under two billion dollars. S. commercial revenue, hitting 764 million dollars.

This shows growing adoption of Palantir’s platform by businesses, alongside steady government demand. 7 billion dollars. Investors rewarded this growth and cash flow strength with a more than ten percent pop in after-hours trading.

Palantir’s ability to combine rapid commercial expansion with improving profitability is helping justify its premium valuation, which has been a point of debate among investors. Snapchat’s parent company Snap also delivered a strong report, shaking off skepticism about its future beyond augmented reality. 6 billion dollars, driven by a nine percent increase in advertising revenue and an impressive eighty five percent jump in other revenue, which includes subscriptions.

This diversification beyond ads is a big deal for Snap, signaling multiple growth engines. Daily active users grew five percent to nearly 500 million, though North American daily users remain down seven percent, highlighting some regional challenges. Snap’s adjusted earnings before interest, taxes, depreciation, and amortization reached 250 million dollars, and free cash flow climbed to 121 million dollars.

The stock surged nearly nineteen percent after hours as investors cheered the clearer path to sustainable growth. 74 billion dollars and earnings before interest, taxes, depreciation, and amortization in the 300 to 350 million dollar range. 4 billion dollars of convertible notes for common stock.

This move reduces long-term debt but raises concerns about dilution over the coming weeks. The market remains split between those who see this as a balance sheet cleanup and those worried about shareholder dilution. In biotech, Replimune surged seven percent following a positive FDA advisory panel vote supporting its melanoma therapy RP1.

The panel’s 10-to-3 vote signals substantial evidence of effectiveness, reviving hopes for approval after a prior rejection. While optimism runs high among traders, some caution remains due to outstanding regulatory concerns. Luckin Coffee climbed six percent after reporting a twenty eight point five percent revenue increase in the second quarter and its first year-over-year decline in delivery expenses since a price war began.

S. Looking ahead to tomorrow’s earnings calendar, several notable names report before the open, including Pfizer, Spotify, McDonald’s, and Caterpillar. After the bell, eyes will be on Advanced Micro Devices, Lucid Group, SpaceX’s public shares, Gilead Sciences, and Bed Bath & Beyond, among others.

These reports will offer fresh insights across tech, healthcare, industrials, and retail sectors. I. adoption and diversified digital revenue streams.

Meanwhile, market watchers will focus on economic data and a busy slate of earnings to gauge whether this momentum can continue. Thanks for listening. Catch you next time on LazyListen.